Don't forget Hugh Alsop was appointed as a non-exec last year. He was CEO of Hatchtech when it secured a $200m commercialization agreement with Dr Reddys (NYSE).
and also he was director of business development at Acrux when it secured a licencing deal with US $335m to Lilly (NYSE).
I'm sure he'll be working towards something similar with Dimerix.
Don't forget Hugh Alsop was appointed as a non-exec last year....
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.025(6.67%) |
Mkt cap ! $25.68M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.0¢ | $387.8K | 1.079M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 394907 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 15948 | 1 |
View Market Depth
| Last trade - 16.10pm 12/12/2024 (20 minute delay) ? |
| DXB (ASX) Chart |